New hope: 6-Month TB drug combo tested in diabetic patients
NCT ID NCT07191834
First seen Sep 30, 2025 · Last updated May 25, 2026 · Updated 25 times
Summary
This study looks at whether a 6-month drug combination containing pretomanid can safely and effectively treat drug-resistant tuberculosis in people with type 2 diabetes. About 60 patients aged 12 and older will take the same four oral drugs, and researchers will compare outcomes between those with and without diabetes. The goal is to find a shorter, safer treatment option for this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RIFAMPICIN-RESISTANT/MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.